Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

Black AJ, McLeod HL, Capell HA, Powrie RH, Matowe LK, Pritchard SC, Collie-Duguid ES, Reid DM (1998) Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 129:716-718 Blum C, Zillikens D, Tony HP,Hartmann AA, Burg A (1993) Soluble interleukin-2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus. Hautarzt 44:290-295 Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE (1993) Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 119:1198-1208 Callen JP (1982) Chronic cutaneous lupus erythematosus: clinical, laboratory, therapeutic, and prognostic examination of 62 patients. Arch Dermatol 118:412-416 Callen JP, Klein J (1988) Subacute cutaneous lupus erythematosus. Clinical, serologic, immuno-

genetic, and therapeutic considerations in 72 patients. Arthritis Rheum 31:1007-1013 Callen JP, Fowler JF, Kulick KB (1985) Serologic and clinical features of patients with discoid lupus erythematosus: relationship of antibodies to single-stranded deoxyribonucleic acid and of other antinuclear antibody subsets to clinical manifestations.J AmAcad Dermatol 13:748-755

Callen JP, Kulick KB, Stelzer G, Fowler JF (1986) Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of 49 patients seen in a non-referral setting. J Am Acad Dermatol 15:1227-1237 Chelbus E, Wolska H, Blaszyk M, Jablonska S (1998) Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J Am Acad Dermatol 38:405-412 Choudhry V, Madan N, Sood SK, Ghai OP (1978) Chloroquine-induced haemolysis and acute renal failure in subjects with G-6-PD deficiency. Trop Geogr Med 30:331-335 Cohen MR, Crosby D (1994) Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus. J Rheumatol 21:1665-1669 Committee on Safety of Medicines/Medicines Control Agency (1997) Blood dyscrasias and other ADRs with low-dose methotrexate. Current Problems 23:12-18 Custer RP (1946) Aplastic anemia in soldiers treated with Atabrine (quinacrine). Am J Med Sci 212:211-224

DahlMGC (1984) Folate depletion in psoriatics on methotrexate.Br J Dermatol 111(Suppl 26):18 Dodd HJ, Kirby JD, Munro DD (1985) Megaloblastic anaemia in psoriatic patients treated with methotrexate. Br J Dermatol 112:630-631 Ettinger WH, Hazzard WR (1988) Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 37:1055-1058 Fonseca E,Alvarez R, Gonzalez MR, Pascual D (1992) Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus. Lupus 1:265-268 Franceschini F, Calzavara-Pinton P, Quinzanini M, Cavazzana I, Bettoni L, Zane C, Facchetti F, Airo P, McCauliffe DP, Cattaneo R (1998) Chilbains lupus erythematosus is associated with antibodies to SSA/Ro. Lupus 8:215-219 Gaffney K, Scott DG (1998) Azathioprine and cyclophasphamide in the treatment of rheumatoid arthritis. Br J Rheum 37:824-836 Johansson-Stephansson E, Koskimes S, Partanen J, Kariniemi AL (1989) Subacute cutaneous lupus erythematosus: genetic markers and clinical and immunological findings in patients. Arch Dermatol 125:791-796 Kersley GD, Palin AG (1959) Amodiaquine and hydroxychloroquine in rheumatoid arthritis. Lancet ii:886-888

Konstadoulakis MM, Kroubouzos G, Tosca A, Piperingos G, Marafelia P, Konstadoulakis M, Varelzidis A, Koutras DA (1993) Thyroid autoantibodies in the subsets of lupus ery-thematosus: correlation with other autoantibodies and thyroid function. Thyroidol Clin Exp 5:1-7

Kremer JM,Alarcon GS, Lightfoot RW Jr,Willkens RF, Furst DE,Williams HJ, Dent PB,Weinblatt ME (1994) Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 37:1829-1830 Landewe RB, Vergouwen MS, Goeei The SG, Van Rijthoven AW, Breedveld FC, Dijkmans BA

(1995) Antimalarial drug induced decrease in creatinine clearance. J Rheumatol 22:34-37 Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M (1994) The autoantibody response to

Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol 130:1262-1268 Ludolph A, Matz DR (1982) Electrophysiologic changes in thalidomide neuropathy under treatment for discoid LE. EEG EMG 13:167-170 Mayou SC, Wojnorowska F, Lovell CR, Asherson RA, Leigh IM (1988) Anticardiolipin and antinuclear antibodies in discoid lupus erythematosus - their clinical significance. Clin Exp Der-matol 13:389-392

Meyerson MA, Cohen PR (1994) Dapsone-induced aplastic anemia in a woman with bullous systemic lupus erythematosus. Mayo Clin Proc 69:1159-1162 Millard LG, Rowell NR (1979) Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients. Arch Dermatol 115:1055-1058

Mok CC, Lau CS, Woon Sing Wong R (1998) Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases. J Rheumatol 25:1246-1247

Musabayane CT,Ndhlovu CE, Balment RJ (1994) The effects of oral chloroquine administration on kidney function. Renal Fail 16:221-228 Neuberger J (1995) Methotrexate and liver disorders. Prescribers' J 35:158-63 O'Loughlin S, Schroeter AL, Jordan RE (1978) A study of lupus erythematosus with particular reference to generalized discoid lupus. Br J Dermatol 99:1-11 Orth DN,Kovacs WJ (1998) The adrenal cortex. In: Wilson JD, Foster DW,KronenbergHM,Larsen PR (eds) Williams textbook of endocrinology, 9th ed. WB Saunders, Philadelphia, pp 517-664 Petri M, Lakatta C, Magder L, Goldman D (1994) Effects of prednisone and hydroxychloroquine on coronary artery disease rise factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 96:254-259 Pistiner M,Wallace DJ,Nessim S, Metzger AL, Klinenberg JR (1991) Lupus erythematosus in the

1980s: a survey of 570 patients. Semin Arthritis Rheum 21:55-64 Polano MK, Cats A, van Olden GAJ (1965) Agranulocytosis following treatment with hydroxy-

chloroqine sulfate. Lancet 1:1275 Provost TT, Ratrie H (1990) Autoantibodies and autoantigens in lupus erythematosus and Sjo-

gren's syndrome. Curr Probl Dermatol 2:150-208 Prystowsky SD, Kerndon JH, Gilliam JN (1975) Chronic cutaneous lupus erythematosus (DLE):

a clinical and laboratory investigation of 80 patients. Medicine 55:183-191 Rowell NR (1984) The natural history of lupus erythematosus. Clin Exp Dermatol 9:217-231 Sanchez NP, Peters MS, Winkelmann RK (1981) The histopathology of lupus erythematosus panniculitis. J Am Acad Dermatol 5:673-680 Schimmer BP, Parker KL (1996) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JE, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds) The pharmacological basis of therapeutics, 9th ed. McGraw-Hill, New York,pp 1459-1485 Shi SY, Feng SF, Liao KH,Fang L, Kang KF (1987) Clinical study of 30 cases of subacute cutaneous lupus erythematosus. Chin Med J 100:45-48 Sontheimer RD (1989) Subacute cutaneous lupus erythematosus: a decade's perspective. Med

Clin North Am 73:1073-1090 Sontheimer RD, Provost TT (1997) Cutaneous manifestations of lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois' lupus erythematosus, 5th ed. Williams & Wilkins, Philadelphia, pp 569-623

Sontheimer RD, Maddison PJ, Richlin M, Jordon RE, Stasny P, Gilliam JN (1982) Serologic and HLA associations in subacute cutaneous lupus erythematosus: a clinical subset of lupus ery-thematosus. Ann Intern Med 97:664-671 Sturdevant RA, Singleton JW, Derern JL, Law DH, McCleery JL (1979) Azathioprine-related pancreatitis in patients with Crohn's disease. Gastroenterology 77:883-886 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) Special article: the 1982 revised criteria for the classification of systemic lupus erythmatosus. Arthritis Rheum 25:1271-1277 Tebbe B, Mansmann U, Wollina U, Auer-Grumbach P, Licht-Mbalyohere A, Arensmeier M, Orfanos CE (1997) Markers in cutaneous lupus erythematosus indicating systemic involvement - a multicenter study on 296 patients. Acta Derm Venereol 77:305-308 Wallace DJ (1989) The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination.

Semin Arthritis Rheum 18:282-296 Wallace DJ, Metzger AL, Stecher VJ, Turnbull BA, Kern PA (1990) Cholesterol-lowering effects of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med 89:322-326 Wallace DJ, Pistiner M, Nessim S, Metzger AL, Klinenberg JR (1992) Cutaneous lupus erythe-matosus without systemic lupus erythematosus: clinical and laboratory features. Semin Arthritis Rheum 21:221-226 Winkelmann RK, Peters MS (1982) Lupus panniculitis. Dermatol Update 135 Wysenbeek AJ, Guedj D, Amit M, Weinberger A (1992) Rash in systemic lupus erythematosus: prevalence and relation to cutaneous and non-cutaneous disease manifestations. Ann Rheum Dis 51:717-719

Was this article helpful?

0 0
Natural Arthritis Relief

Natural Arthritis Relief

Natural Arthritis Relief details a unique method of reversing Rheumatoid Arthritis Symptoms by removing numerous arthritis triggers as well as toxins using a simple 5 step natural process.

Get My Free Ebook

Post a comment